Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3 trillion market

• Abu Dhabi’s new Health, Endurance, Longevity, and Medicine (HELM) cluster to bolster
  life sciences ecosystem in Abu Dhabi, cementing the emirate’s position as the leading
  global hub for biotechnology, MedTech and digital health innovation
• The cluster is projected to contribute $25.6 billion to Abu Dhabi’s GDP, unlock 30,000
  new jobs, and attract $11.5 billion in investment by 2045
  Abu Dhabi, United Arab Emirates, 16 April 2025:
  Abu Dhabi has launched the groundbreaking life sciences cluster, reinforcing its position as a
  global hub for biotechnology, MedTech, and digital health. Developed by the Abu Dhabi
  Department of Economic Development, Abu Dhabi Investment Office (ADIO) and the
  Department of Health – Abu Dhabi, the Health, Endurance, Longevity, and Medicine (HELM)
  cluster is designed to drive healthcare innovation, attract international investment, and deliver
  lasting benefits to global populations.
  Announced during Abu Dhabi Global Health Week, the HELM cluster will serve as a platform
  for the research, development, manufacturing and commercialisation of advanced health and life
  science solutions. From AI-powered diagnostics and pharmaceutical manufacturing to gene
  therapies and precision medicine, the cluster is poised to enable global companies to transform
  breakthrough science into scalable and accessible, patient-focused solutions.
  With its world-class infrastructure, progressive regulations, and strategic geographic location,
  Abu Dhabi offers unparalleled access to global markets. The emirate’s multicultural talent base,
  advanced biomanufacturing facilities, and commitment to innovation make it an ideal launchpad
  for life sciences companies looking to scale globally.
  His Excellency Ahmed Jasim Al Zaabi, Chairman of the Abu Dhabi Department of
  Economic Development, said: “The Abu Dhabi Health, Endurance, Longevity, and Medicine
  (HELM) cluster will provide global and local stakeholders with a wide range of benefits,
  including access to cutting-edge technologies, world-class infrastructure and progressive
  regulatory frameworks. By creating a globally competitive life sciences hub, we are not only
  accelerating economic growth and diversification, but we are also ensuring that Abu Dhabi
  remains at the forefront of developing breakthrough healthcare solutions that will benefit
  humanity at large.”
  Built to meet the rising global demand for advanced healthcare, the cluster is designed to tackle
  some of the world’s most pressing health challenges, including chronic and non-communicable
  diseases, which account for over 70% of deaths globally, as well as the healthcare needs of
  ageing populations. It is tapping growth opportunities in the global healthcare market, which is
  projected to reach $25.3 trillion (AED93 trillion) by 2045.
  His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health –
  Abu Dhabi, said: “The launch of Abu Dhabi’s Health, Endurance, Longevity, and Medicine

cluster is a bold leap forward in how the world delivers healthcare. We are not just investing in
infrastructure, we’re investing in human potential, in breakthroughs that will redefine longevity,
and in solutions that will reach far beyond our borders. This is where innovation meets impact.”
Leveraging an innovation-friendly regulatory framework, Abu Dhabi empowers companies to
bring breakthrough technologies to market faster, shaping the future of healthcare at speed and
scale. Its AI-powered health system and leadership in precision medicine create an environment
where innovation thrives across the entire value chain.
As home to one of the world’s largest national genomics programme, the emirate supports
research and development by fostering insights from a uniquely diverse genomic landscape,
accelerating innovation and advancing the global shift toward personalised treatments.” At the
same time, Abu Dhabi is strengthening its role in the global pharmaceutical supply chain,
offering reliable infrastructure, strategic connectivity, and long-term partnership opportunities for
companies navigating an increasingly complex global landscape.
By 2045, the HELM cluster is expected to contribute $25.6 billion (AED 94 billion) to Abu
Dhabi’s GDP, attract $11.5 billion (AED 42 billion) in investment, and create 30,000 high-value
jobs, supporting the diversification of the emirate’s economy while enabling long-term global
health impact.
The cluster is part of Abu Dhabi’s broader strategy to lead globally in emerging industries. It
follows the successful launch of the Smart and Autonomous Vehicle Industries (SAVI) cluster in
2023, which addresses smart urban mobility across air, land, and sea– and the AgriFood Growth
and Water Abundance (AGWA) cluster in 2024, which addresses food security and water
sustainability challenges.
Source: AETOSWire

ghnewsexpress